[O13] 一般演題13「Cancer 2」

[O13-8] Metformin and the oncolytic HSV C-REV combination promote antitumor efficacy in a bilateral pancreatic cell cancer subcutaneous model

^○Mohamed Abdelmoneim^1,2,3, Ibrahim Ragab Eissa^1,2,4, Mona Alhussein Aboalela^1,2,5, Yoshinori Naoe¹, Shigeru Matsumura¹, Patricia Sibal¹, Itzel Bustos-Villalobos¹, Maki Tanaka⁶, Yasuhiro Kodera², Hideki Kasuya¹ (1.Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Nagoya, Japan, 2.Department of Surgery II, Graduate School of Medicine, Nagoya University, Japan, 3.Department of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt, 4.Faculty of Science, Tanta University, Tanta, Egypt, 5.Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig. Egypt., 6.Takara Bio Inc., Kusatsu, Shiga, Japan)